Financial information

The information source is the annual report of the company with business id 556548-2329

* Closing information (×1000) SEK

Fiscal year 202404 202304 202204
Number of months: 12 12
Turnover: 28,930 Revenue Up 28,888 Revenue Up 26,877
Financial expenses: 170 Revenue Up 60 Revenue Up 45
Earnings before taxes: 617 Revenue Up -1,022 Revenue Down 129
Total assets: 18,565 Revenue Up 15,173 Revenue Up 13,922
Current assets: 11,139 Revenue Up 8,043 Revenue Down 8,742
Current liabilities: 6,753 Revenue Up 4,823 Revenue Up 2,808
Equity capital: 5,105 Revenue Up 4,644 Revenue Down 6,047
Share capital: 2,200 2,200 2,200
Number of employees: 15 15 15

Financial ratios

Solvency: 27.5% Revenue Down 30.6% Revenue Down 43.4%
Turnover per employee: 1,929 Revenue Up 1,926 Revenue Up 1,792
Profitability: 2.1% Revenue Up -3.5% Revenue Down 0.5%
Return on equity (ROE): 12.1% Revenue Up -22.0% Revenue Down 2.1%
Current ratio: 164.9% Revenue Down 166.8% Revenue Down 311.3%
Return on assets (ROA): 4.2% Revenue Up -6.3% Revenue Down 1.2%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202404
Number of months: 12
Turnover: 28,930
Financial expenses: 170
Earnings before taxes: 617
Total assets: 18,565
Current assets: 11,139
Current liabilities: 6,753
Equity capital: 5,105
Share capital: 2,200
Number of employees: 15

Financial ratios

Solvency: 27.5%
Turnover per employee: 1,929
Profitability: 2.1%
Return on equity (ROE): 12.1%
Current ratio: 164.9%
Return on assets (ROA): 4.2%